slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5.410 KRW | 0,00% | +0,19% | -12,60% |
09/04 | Het aandeleninkoopplan van Jin Yang Pharmaceutical Co., Ltd. verlengd tot 9 april 2025. | CI |
2023 | Jin Yang Pharmaceutical Co. Ltd.'s Aandeleninkoopplan verlengd tot 22 december 2024. | CI |
Omzet 2022 | 76,26 mld. 55,44 mln. 51,86 mln. | Omzet 2023 | 94,11 mld. 68,42 mln. 64 mln. | Marktkapitalisatie | 66,81 mld. 48,57 mln. 45,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 12,31 mld. 8,95 mln. 8,37 mln. | Nettowinst (verlies) 2023 | 12,66 mld. 9,2 mln. 8,61 mln. | EV/omzet 2022 | 1,05 x |
Nettoschuld 2022 | 9,49 mld. 6,9 mln. 6,45 mln. | Nettoschuld 2023 | 4,34 mld. 3,16 mln. 2,95 mln. | EV/omzet 2023 | 0,76 x |
K/w-verhouding 2022 |
6,61
x | K/w-verhouding 2023 |
5,27
x | Werknemers | 220 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 59,84% |
1 week | +0,19% | ||
Lopende maand | -8,92% | ||
1 maand | -9,68% | ||
3 maanden | -8,92% | ||
6 maanden | -10,43% | ||
Lopend jaar | -12,60% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jae-Jun Choi
CEO | Chief Executive Officer | 54 | - |
Yoon-Hwan Choi
CHM | Chairman | 87 | - |
Jong-Gu Im
BRD | Director/Board Member | 66 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yoon-Hwan Choi
CHM | Chairman | 87 | - |
Jae-Jun Choi
CEO | Chief Executive Officer | 54 | - |
Jong-Gu Im
BRD | Director/Board Member | 66 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 5.410 | 0,00% | 16 179 |
25-04-24 | 5.410 | -0,92% | 7 565 |
24-04-24 | 5.460 | +0,18% | 6 160 |
23-04-24 | 5.450 | +0,55% | 10 289 |
22-04-24 | 5.420 | +0,37% | 6 706 |
slotkoers Korea S.E., 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-12,60% | 42,42 mln. | |
+19,62% | 43,34 mld. | |
+20,44% | 21,96 mld. | |
+10,86% | 14,09 mld. | |
+13,07% | 13,64 mld. | |
+37,46% | 11,43 mld. | |
-8,59% | 6,86 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+8,46% | 5,22 mld. |